Tell us about your search experience on the TGA website - complete our short survey
Consultation on low value turnover exemption (LVT) scheme
Published
Related content
- TGA opens consultation on the use of prescription opioids for painThe TGA has issued a discussion paper on the use and misuse of prescription strong opioids, such as oxycodone, and whether there is a need for specific regulatory responses
- Proposal to change the current Good Manufacturing Practice (GMP) fees and chargesTGA clarification on the recent article from Pharma in Focus
- New transparency measures for prescription medicinesThe Australian Government has given approval to proceed with two measures to enhance transparency for prescription medicines